Breast cancer individual denied Medicaid coverage: Is he victim of sexism?

Breast cancer individual denied Medicaid coverage: Is he victim of sexism? Medicaid recently declined to cover the cost of treatment for breast cancer because the patient met all the eligibility requirements but one. One that says the individual needs to be a woman. Raymond Johnson, of Cross, S.C., got the shocking news that he previously a breasts malignancy last month after going to the emergency space to find out that which was causing his upper body pain.Kaiser Health News, an unbiased news service editorially, is an application of the Kaiser Family members Foundation, a nonpartisan health care policy research firm unaffiliated with Kaiser Permanente.

AstraZeneca begins selumetinib Stage 3 clinical trial in NSCLC patients AstraZeneca today announced the first individual randomized in a Stage 3 clinical trial for selumetinib, an oral, potent, selective MEK inhibitor, getting investigated as second-range therapy in individuals with advanced or metastatic non-small-cell lung cancers whose tumors are KRAS mutation-positive.